**Question:** "SAFE" strategy for control of trachoma; 'S'-stands for: September 2008

**Core Concept:** The SAFE strategy is a World Health Organization (WHO) approach to control and eliminate trachoma, a neglected tropical disease caused by the bacterium Chlamydia trachomatis. The strategy aims to address the main Trachoma Elimination Targets (TETs) and their timeline for implementation.

**Why the Correct Answer is Right:** In the context of the SAFE strategy, 'S' stands for Surgery (Surgical management of trichiasis). Surgery helps to correct the condition of trichiasis, where the eyelashes grow inwards and scratch the cornea, leading to corneal damage and blindness. The SAFE strategy was introduced in September 2008 to provide a comprehensive approach to trachoma control.

**Why Each Wrong Option is Incorrect:**

A. Antibiotic - Targeting the bacterium Chlamydia trachomatis is essential in controlling trachoma. However, the 'A' stands for Antibiotic (Azithromycin) administration, not surgery. This option refers to mass drug administration (MDA) as part of the SAFE strategy.

B. Antibiotic - Similar to option A, the 'A' stands for Antibiotic administration, specifically Azithromycin, which is an essential part of the SAFE strategy for trachoma control.

C. Antibiotic - This option also refers to mass drug administration (MDA) with Azithromycin, which is crucial for the control of trachoma. However, it lacks mention of surgery and does not align with the full SAFE strategy.

D. Antibiotic - Azithromycin is a crucial component of the SAFE strategy, targeting the bacterium Chlamydia trachomatis. However, it does not mention the importance of surgery (S) for managing trichiasis and preventing complications from trachoma.

**Correct Answer:**

**Core Concept:** The SAFE strategy involves a comprehensive approach to trachoma control, including surgery, antibiotics, facial cleanliness, and environmental improvement.

**Why the Correct Answer is Right:**

The correct answer is D, which stands for Mass Drug Administration (MDA) of Azithromycin. Mass drug administration is a critical component of the SAFE strategy, as it helps to reduce the prevalence of active trachoma (inflammation stage) in the community. This intervention is aimed at reducing transmission of Chlamydia trachomatis, the causative agent of trachoma, by administering Azithromycin to vulnerable populations (children and their immediate contacts).

**Why Each Wrong Option is Incorrect:**

A, B, C, and E all refer to the administration of Azithromycin, which is essential for reducing the prevalence of trachoma (inflammation stage) in the community. However, they do not emphasize the importance of surgery (S) for managing trichiasis (involving surgical correction of trichiasis and prevention of complications from trach